We are live on ! Find out more
NSPR icon

InspireMD

35 hedge funds and large institutions have $34.7M invested in InspireMD in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 1

17% more funds holding

Funds holding: 3035 (+5)

4% more capital invested

Capital invested by funds: $33.4M → $34.7M (+$1.34M)

5.23% less ownership

Funds ownership: 48.74%43.51% (-5.2%)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $9K

Holders
35
Holders Change
+5
Holders Change %
+16.67%
% of All Funds
0.47%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
7
Increased
4
Reduced
5
Closed
1
Calls
Puts
$9K
Net Calls
-$9K
Net Calls Change
-$10K

NSPR Hedge Fund Activity: Q1 2025 in Review

35 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q1 2025, worth a combined $34.7M — up 4% from $33.4M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new NSPR positions and 1 closed out — a net gain of 6 holders — while 4 added to existing stakes and 5 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $1.82M. The largest seller was Soleus Capital Management, cutting an estimated $1.22M.

  • 35 institutional investors held InspireMD (NSPR) as of Q1 2025, up from 30 in Q4 2024.
  • Funds reported $34.7M of InspireMD stock for Q1 2025, up 4% quarter-over-quarter.
  • 7 funds opened new InspireMD positions in Q1 2025 and 1 closed out, a net change of +6 holders.
  • The largest InspireMD buyer in Q1 2025 was Nantahala Capital Management, an estimated $1.82M added.
  • The largest InspireMD seller in Q1 2025 was Soleus Capital Management, an estimated $1.22M sold.

Based on aggregated 13F filings for Q1 2025.